News
Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on July 10, 2025, the Compensation Committee of the Board ...
China has about 20 million patients with rare diseases, with more than 200,000 new cases each year. The first batch of treatment guidelines was published in 2019 and covered 121 rare diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results